Product Number |
ARP52414_P050 |
Product Page |
www.avivasysbio.com/centb5-antibody-n-terminal-region-arp52414-p050.html |
Name |
CENTB5 Antibody - N-terminal region (ARP52414_P050) |
Protein Size (# AA) |
759 amino acids |
Molecular Weight |
85kDa |
NCBI Gene Id |
116983 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
0.5 mg/ml |
Gene Full Name |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 |
Alias Symbols |
CENTB5 |
Peptide Sequence |
Synthetic peptide located within the following region: LQSFVKEDVRKFKETKKQFDKVREDLELSLVRNAQAPRHRPHEVEEATGA |
Product Format |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reference |
Gerhard,D.S., Genome Res. 14 (10B), 2121-2127 (2004) |
Description of Target |
CENTB5 is a GTPase-activating protein for the ADP ribosylation factor family. |
Protein Interactions |
TAB1; SLC35G2; EIF6; |
Reconstitution and Storage |
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-ACAP3 (ARP52414_P050) antibody |
Blocking Peptide |
For anti-ACAP3 (ARP52414_P050) antibody is Catalog # AAP52414 (Previous Catalog # AAPS31701) |
Immunogen |
The immunogen is a synthetic peptide directed towards the N terminal region of human CENTB5 |
Uniprot ID |
Q96P50 |
Protein Name |
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 |
Protein Accession # |
NP_085152 |
Purification |
Affinity Purified |
Nucleotide Accession # |
NM_030649 |
Tested Species Reactivity |
Human |
Gene Symbol |
ACAP3 |
Predicted Species Reactivity |
Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Zebrafish |
Application |
WB |
Predicted Homology Based on Immunogen Sequence |
Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rat: 100%; Zebrafish: 86% |
Image 1 | Human Pancreas
| WB Suggested Anti-CENTB5 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: Human Pancreas |
|
|